logo
Select company
Select metric
$ -7.1MNet Cash Flow - Investment Acquisitions and Disposals
VS
Market
23
Sector
20
Industry
20
History
38
$ 14.26Close
$ 8.21 - $ 14.6 52-Week Range
Ticker Information

Ticker

TBPH

Company Name

THERAVANCE BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

THERAVANCE BIOPHARMA INC - Net Cash Flow - Investment Acquisitions and Disposals Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TBPH - CF - Investments Historical data
DateNet Cash Flow - Investment Acquisitions and Disposals
6/30/2025$ -7.1M
3/31/2025$ 26.13M
12/31/2024$ 12.62M
9/30/2024$ -3.26M
6/30/2024$ 14.12M
3/31/2024$ 27.71M
12/31/2023$ -31.72M
9/30/2023$ 7.71M
6/30/2023$ -14.79M
3/31/2023$ -17.77M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • THERAVANCE BIOPHARMA INC's latest trailing twelve months (TTM) CF - Investments stands at $ -20.95M.
  • Over the past 5 years, THERAVANCE BIOPHARMA INC's average CF - Investments has been $ 39.19M.
  • The median CF - Investments for THERAVANCE BIOPHARMA INC during this period was $ 15.86M
  • THERAVANCE BIOPHARMA INC reached its highest CF - Investments over the past 5 years at $ 273.52M.
  • The lowest CF - Investments recorded by THERAVANCE BIOPHARMA INC in the same timeframe $ -31.72M

THERAVANCE BIOPHARMA INC's CF - Investments vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Investments Benchmarks
CompanyCF - Investments
SAGE : SAGE THERAPEUTICS INC $ 254.43MKURA : KURA ONCOLOGY INC $ -89.77MZVRA : ZEVRA THERAPEUTICS INC $ -158.04MNKTR : NEKTAR THERAPEUTICS $ 136.11MGYRE : GYRE THERAPEUTICS INC $ -3.08MNRIX : NURIX THERAPEUTICS INC $ 17.67MEYPT : EYEPOINT PHARMACEUTICALS INC $ 11.55MSNDX : SYNDAX PHARMACEUTICALS INC $ -46.1MADCT : ADC THERAPEUTICS SA $ 0YMAB : Y-MABS THERAPEUTICS INC $ 0

Similar metrics to CF - Investments:

Definition of Net Cash Flow - Investment Acquisitions and Disposals

[Cash Flow Statement] A component of cash flow from investing [NCFI], representing the cash inflow (outflow) from disposal (acquisition) of investments. Includes marketable securities and loan originations.

TBPH - Net Cash Flow - Investment Acquisitions and Disposals, Last 5 years

$ -31.72M

Minimum

Dec 31, 2023

$ 273.52M

Maximum

Jun 30, 2021

$ 39.19M

Average

$ 15.86M

Median

CF - Investments Benchmark Analysis

 The chart above depicts the distribution of CF - Investments for companies in the Total Stock Market. The average CF - Investments of the companies is $ 36.68K with a standard deviation of $ 2.27M.
The following table provides additional summary stats:
CF - Investments in the Market:
filtered constituents2.5K
min$ -9.71M
max$ 9.69M
average$ 36.68K
median$ 0
std$ 2.27M